A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
Clinical trial NCT06854653 · RECRUITING
Trial details
- NCT number
- NCT06854653
- Sponsor
- Prescient Therapeutics, Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-28
- Primary completion
- 2028-01-01
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.